Radical radiotherapy for bronchogenic carcinoma: five year survival rates

Clinical Oncology : a Journal of the Royal College of Radiologists
G A Newaishy, G R Kerr

Abstract

A total of 443 patients with bronchogenic carcinoma were treated by radical radiotherapy. Their 5-year survival rate was 10.5%, median survival 57 weeks. Of these patients 42 (9.5%) had postoperative residual or recurrent tumour. Their 5-year survival rate was 14.3%, median 80 weeks. The corresponding figures for the 401 patients who had had no previous therapy were 10.2% and 54 weeks. The tumour was histologically confirmed in 277 patients; their 5-year survival rate was 6.9%, median 54 weeks. The corresponding figures for the 166 patients who had no positive histology were 16.9% and 61 weeks. The 5-year survival rate of 235 patients with positive histology who had no surgery was 5.5%, median 51 weeks. Age and sex had no significant influence on survival. Tumour size and regional lymph node status had a marked influence on survival. The 5-year survival rate was 27.5% for patients who had T1 tumours and 8.2% for those with T2/3 tumours (P less than 0.001), median 125 and 51.5 weeks, respectively. The lymph node status was recorded in 72% of patients. The 5-year survival rate of patients who had nodal involvement was 7.4% (median 44 weeks) and 18.6% for those who had no apparent lymph node involvement (median 71 weeks), P less t...Continue Reading

References

Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·C A PerezR Birch
Apr 1, 1984·International Journal of Radiation Oncology, Biology, Physics·H G Seydel
Dec 1, 1983·International Journal of Radiation Oncology, Biology, Physics·N Green, H Weinstein
Jul 1, 1983·International Journal of Radiation Oncology, Biology, Physics·C Schaake-KoningD Gonzalez Gonzalez

❮ Previous
Next ❯

Citations

Aug 1, 1979·International Journal of Radiation Oncology, Biology, Physics·J C RuckdeschelJ Horton
Aug 1, 1980·International Journal of Radiation Oncology, Biology, Physics·N M Bleehen
Jan 15, 1995·International Journal of Radiation Oncology, Biology, Physics·P H GrahamA O Langlands
Mar 1, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Martin WeinmannMichael Bamberg
Mar 7, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sol San JoséFerran Guedea
Nov 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·G A Newaishy, C G Kelly
Mar 10, 2004·Hematology/oncology Clinics of North America·Frank B ZimmermannBranislav Jeremic
Nov 1, 1989·Clinical Oncology : a Journal of the Royal College of Radiologists·P A BurtR Stout
Sep 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P A Lawton, E J Maher
Sep 26, 2003·Seminars in Surgical Oncology·Martin WeinmannBranislav Jeremic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.